A Functional Polymorphism of the μ-Opioid Receptor Gene is Associated with Naltrexone Response in Alcohol-Dependent Patients
Top Cited Papers
Open Access
- 23 April 2003
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 28 (8), 1546-1552
- https://doi.org/10.1038/sj.npp.1300219
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A genetic association study of the mu opioid receptor and severe opioid dependencePsychiatric Genetics, 2003
- Posttreatment Results of Combining Naltrexone with Cognitive-Behavior Therapy for the Treatment of AlcoholismJournal of Clinical Psychopharmacology, 2001
- Nonreplication of association between ?-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependenceAmerican Journal of Medical Genetics, 2001
- A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NALTREXONE IN THE TREATMENT OF ALCOHOL DEPENDENCE OR ABUSEAlcohol and Alcoholism, 2000
- Genetics of two μ opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjectsMolecular Psychiatry, 1999
- Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addictionProceedings of the National Academy of Sciences of the United States of America, 1998
- μ opioid receptor gene variants: lack of association with alcohol dependenceMolecular Psychiatry, 1997
- Human mu opioid receptor gene polymorphisms and vulnerability to substance abuseAddiction Biology, 1997
- Assessment of Medication Compliance in Alcoholics through UV Light Detection of a Riboflavin TracerAlcohol: Clinical and Experimental Research, 1996
- New Methodologies for Pharmacological Treatment Trials for Alcohol DependenceAlcohol: Clinical and Experimental Research, 1996